IP Library Granted Patent US 9,821,086
Granted Patent B2
US 9,821,086 · App. 14/962,897 · Granted Nov 21, 2017

Hyaluronic acid-collagen matrices for dermal filling and volumizing applications

Inventors: Xiaojie Yu (Irvine, CA); Nicholas J. Manesis (Summerland, CA); Jacob Pollock (Charleston, WV)
Assignee: Allergan, Inc.
A61L27/24A61K8/042A61K8/735A61L27/26A61L27/3695A61L27/52A61Q19/08A61K2800/91A61L2400/06A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,821,086
App. No.
14/962,897
Granted
Nov 21, 2017
Kind
B2
Abstract

Hydrogels comprising a macromolecular matrix and water may be used for aesthetic fillers, for example, dermal fillers. The macromolecular matrix may include a crosslinked combination of hyaluronic acid and collagen.

Claims (24)

1. A method of generating adipose tissue in a soft tissue of a human subject, the method comprising:

contacting a hydrogel composition with adipose tissue ex vivo to provide a hydrogel/adipose tissue mixture; and

subcutaneously injecting the mixture into the soft tissue of the subject;

wherein the hydrogel composition comprises:

(i) water; and

(ii) a hyaluronic acid crosslinked with a collagen via a plurality of crosslink units, wherein at least a portion of the crosslink units comprise an amide bond; and wherein

the hyaluronic acid concentration is from 6 mg/mL to 20 mg/mL;

the collagen concentration is from 3 mg/mL to 12 mg/mL;

the hyaluronic acid:collagen weight ratio is from 1:1 to 7:1; and

the hydrogel has a storage modulus value of between 850 Pa and 5,000 Pa;

thereby generating an additional amount of the adipose tissue in the soft tissue of the subject.

2. The method of claim 1 , wherein the collagen comprises collagen type I, collagen type III, or a combination thereof.

3. The method of claim 1 , wherein the collagen is collagen type I.

4. The method of claim 2 or 3 , wherein the collagen is derived from a human or porcine source.

5. The method of claim 1 , wherein the hyaluronic acid has a molecular weight of about 1,000,000 Da to about 5,000,000 Da.

6. The method of claim 1 , wherein the hyaluronic acid has a molecular weight of about 1,000,000 Da to about 3,000,000 Da.

7. The method of claim 1 , wherein the ratio of the hyaluronic acid to the collagen is 1:1 to 2:1.

8. The method of claim 1 , wherein the ratio of the hyaluronic acid to the collagen is 1:1.

9. The method of claim 1 , wherein the hydrogel has a storage modulus value of between 1,000 Pa and 5,000 Pa.

10. The method of claim 1 , wherein the hydrogel has a hyaluronic acid concentration of 12 mg/mL or 16 mg/mL.

11. The method of claim 1 , wherein the hydrogel has a collagen concentration of 6 mg/mL, 8 mg/mL or 12 mg/mL.

12. The method of claim 1 , wherein the hydrogel has a hyaluronic acid concentration of 12 mg/mL and a collagen concentration of 6 mg/m L.

13. The method of claim 1 , wherein the hydrogel has a hyaluronic acid concentration of 12 mg/mL and a collagen concentration of 12 mg/mL.

14. The method of claim 1 , wherein the hydrogel has a hyaluronic acid concentration of 16 mg/mL and a collagen concentration of 8 mg/m L.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2017
From: YU, XIAOJIE; MANESIS, NICHOLAS J.
To: ALLERGAN, INC.
Reel/Frame 042542/0409 →
Continuity (6)
Division 13667581 · Nov 2, 2012
Continuation In Part 13605565 · Sep 6, 2012
Continuation In Part 13603213 · Sep 4, 2012
Provisional Application 61555970 · Nov 4, 2011
Provisional Application 61531533 · Sep 6, 2011
Related Publication 20160089475A1 · Mar 31, 2016